Bill Snyder

elderly Asian mother and adult daughter
August 7, 2017

Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

By Bill Snyder
Happy african couple embracing in front of their new house.
August 3, 2017

Researchers study unique couples intervention in Mozambique to reduce HIV transmission

Researchers in the Vanderbilt Institute for Global Health are testing whether a unique “couples-centered” intervention developed in the southern African nation of Mozambique can reduce mother-to-child transmission of HIV.

By Bill Snyder
spotlight on a black background
July 27, 2017

Investigators use light to kill microbial ‘vampires’

On July 24 Vanderbilt scientist Eric Skaar, Ph.D., MPH, summarized his group’s latest paper in a tweet: “If S. aureus is going to drink our blood like a vampire, let’s kill it with sunlight.”

By Bill Snyder
July 27, 2017

Doris Duke Foundation lauds Van Driest’s research

Sara Van Driest, M.D., Ph.D., who is developing methods for precision dosing of pediatric medications at Vanderbilt University Medical Center (VUMC), has received a 2017 Clinical Scientist Development Award from the Doris Duke Charitable Foundation.

By Bill Snyder
Last week’s workshop was sponsored by the American Society of Matrix Biology and the Vanderbilt Center for Matrix Biology. (photo by Julie Hudson)
July 27, 2017

Workshop draws basement membrane experts from across globe

A workshop on the basement membrane hosted earlier this month by Vanderbilt University Medical Center attracted 75 top scientists from around the world and broke new ground in understanding molecules that make up this key biological structure.

By Bill Snyder
H. Alex Brown, Ph.D.
July 26, 2017

Vanderbilt mourns loss of pharmacologist H. Alex Brown

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology at Vanderbilt University School of Medicine, died from cancer Tuesday, July 25, at his home. He was 56.

By Bill Snyder
July 24, 2017

How Epo action is ‘enhanced’

The hormone erythropoietin (Epo) controls red blood cell production and synthetic forms of Epo treat multiple disorders. New Vanderbilt research details how Epo works.
By Bill Snyder
July 20, 2017

Study identifies protein’s role in chemotherapy resistance

Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2.
By Bill Snyder
July 20, 2017

Immune responses linked to cell’s recycling system

Autophagy is the cellular equivalent of trash pickup and recycling — it is a process by which proteins, protein aggregates and damaged cellular organelles are degraded in order to reuse nutrients and promote cellular metabolism.
By Bill Snyder
July 20, 2017

Aspirnaut program helps launch students into science

Now in its ninth year, a unique summer research program at Vanderbilt University Medical Center (VUMC) designed primarily for rural students with limited resources is proving that talent has no zip code.
By Bill Snyder
July 20, 2017

eSmart portal set to bolster clinical research enterprise

About 250 research staff members attended an EpicLeap for Research Town Hall on Monday to learn what they must do to prepare for the Nov. 2 launch of eStar, Vanderbilt University Medical Center’s version of the Epic clinical, administrative and billing software system.
By Bill Snyder
July 13, 2017

Lindsell named to key VICTR, IMPH and Biostatistics leadership roles

Christopher Lindsell, Ph.D., nationally known for building clinical, translational and emergency medicine research programs at the University of Cincinnati, has been named director of the Research Methods Program in the Vanderbilt Institute of Clinical and Translational Research (VICTR).
By Bill Snyder
1 … 64 65 66 67 68 … 115